Navigation Links
Black Henna Tattoo Chemical Can Cause Skin Reaction
Date:7/31/2008

Additive to popular markings puts wearers at risk for allergic dermatitis, eczema, scarring, dermatology group warns.,,

THURSDAY, July 31 (HealthDay News) -- Black henna tattoos contain a chemical called para-phenylenediamine (PPD) that can cause serious skin reactions, the American Academy of Dermatology (AAD) warns.

The popular black henna tattoos are sold everywhere from summer carnivals and open-air malls to vacation spots and cruise ships.

PPD, commonly used for black hair dye, is added to natural henna in order to increase the intensity and longevity of the temporary tattoo. The U.S. Food and Drug Administration prohibits the direct application of PPD to the skin because of known health risks. However, lack of regulation of the tattoo industry means people are getting black henna tattoos and putting themselves at risk for serious skin problems.

"Perhaps the most alarming issue we are seeing with black henna tattoos is the increase in the number of children -- even children as young as four -- who are getting them and experiencing skin reactions," Dr. Sharon E. Jacob, assistant clinical professor of pediatrics and medicine (dermatology) at the University of California, San Diego, said in an AAD news release.

She was to present her findings at the AAD's summer meeting in Chicago this week.

"Kids make up a significant portion of the population that receives temporary tattoos, because parents mistakenly think they are safe, since they are not permanent and are available at so many popular venues catering to families. In fact, nothing could be further from the truth," Jacob said.

To date, there have been hundreds of reports of black tattoos causing allergic contact dermatitis, with reactions ranging from mild eczema to blistering and permanent scarring, she noted. Signs of an allergic reaction include redness and itching, bumps, swelling and blisters. Topical steroids can stop the
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Consumer Alert: Black Henna Tattoos Can Cause Serious Skin Reactions
2. LegalView Reveals Details of the FDA Mandated Black Box Warning For Fluoroquinolone Antibiotics Such as Cipro and Levaquin
3. FDA Advisers Dont Back Black Box Warning for Epilepsy Drugs
4. pMDsoft 4.1 for BlackBerry Takes Appointments and Call Schedule Wireless
5. FDA Mandates Black Box Warning for Some Antibiotics
6. Aflac Named as a Top Company for Diversity by Black Enterprise Magazine
7. Religious Coalition for Reproductive Choice to Hold National Black Religious Summit on Sexuality
8. Beware the Blackberry Thumb
9. No Matter the Doctor, Black Diabetics Fare Worse Than White Counterparts
10. Morthers obesity a factor in newborn deaths for blacks, not whites, new study reports
11. Family History Plays Role in Black Colon Screen Rates
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Bradmer announces 2008 fourth quarter and fiscal year operational and financial results 2Health News:Bradmer announces 2008 fourth quarter and fiscal year operational and financial results 3Health News:Bradmer announces 2008 fourth quarter and fiscal year operational and financial results 4Health News:Bradmer announces 2008 fourth quarter and fiscal year operational and financial results 5Health News:Bradmer announces 2008 fourth quarter and fiscal year operational and financial results 6Health News:Bradmer announces 2008 fourth quarter and fiscal year operational and financial results 7Health News:Bradmer announces 2008 fourth quarter and fiscal year operational and financial results 8Health News:Bradmer announces 2008 fourth quarter and fiscal year operational and financial results 9Health News:Orexigen(R) Therapeutics Names Michael Narachi, 24-Year Biopharmaceutical Veteran, New President and Chief Executive Officer 2Health News:Orexigen(R) Therapeutics Names Michael Narachi, 24-Year Biopharmaceutical Veteran, New President and Chief Executive Officer 3Health News:Orexigen(R) Therapeutics Names Michael Narachi, 24-Year Biopharmaceutical Veteran, New President and Chief Executive Officer 4Health News:Virus evolution topic of Darwin talk at UH April 2 2Health News:Study Casts Doubt on Influential Hospital Safety Survey 2Health News:Study Casts Doubt on Influential Hospital Safety Survey 3Health News:Novavax Reports Fourth Quarter and 2008 Year-End Financial Results 2Health News:Novavax Reports Fourth Quarter and 2008 Year-End Financial Results 3Health News:Novavax Reports Fourth Quarter and 2008 Year-End Financial Results 4Health News:Novavax Reports Fourth Quarter and 2008 Year-End Financial Results 5Health News:Novavax Reports Fourth Quarter and 2008 Year-End Financial Results 6Health News:Novavax Reports Fourth Quarter and 2008 Year-End Financial Results 7Health News:Novavax Reports Fourth Quarter and 2008 Year-End Financial Results 8Health News:Novavax Reports Fourth Quarter and 2008 Year-End Financial Results 9Health News:National Council on Disability Calls for New Federal Approach to Disability Policy 2
Breaking Medicine Technology:Lentigen Awarded Phase I SBIR Grant for Hepatitis C Vaccine 2Medco, State of Illinois and Community Retail Pharmacies Launch 'Wired' Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs 2Medco, State of Illinois and Community Retail Pharmacies Launch 'Wired' Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs 3Medco, State of Illinois and Community Retail Pharmacies Launch 'Wired' Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs 4Medco, State of Illinois and Community Retail Pharmacies Launch 'Wired' Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs 5Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 2Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 3Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 4Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 5Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 6Donor Stem Cell Transplant Best For Acute Myeloid Leukemia 48368 1Donor Stem Cell Transplant Best For Acute Myeloid Leukemia 48368 2Donor Stem Cell Transplant Best For Acute Myeloid Leukemia 48368 3Health care issues lead latest Arizona State University Southwest Poll 48364 1Health care issues lead latest Arizona State University Southwest Poll 48364 2Health care issues lead latest Arizona State University Southwest Poll 48364 3Health care issues lead latest Arizona State University Southwest Poll 48364 4Story tips from the Department of Energys Oak Ridge National Laboratory June 2009 8774 1Story tips from the Department of Energys Oak Ridge National Laboratory June 2009 8774 2Story tips from the Department of Energys Oak Ridge National Laboratory June 2009 8774 3